Activation of JAK/STAT signal pathway predicts poor prognosis of patients with gliomas
- 5 February 2010
- journal article
- Published by Springer Nature in Medical Oncology
- Vol. 28 (1), 15-23
- https://doi.org/10.1007/s12032-010-9435-1
Abstract
JAK/STAT pathway transmits signals from the cell membrane to the nucleus in response to extracellular growth factors and cytokines. Activation of this pathway has been found in certain types of human tumors. The goal of this study was to investigate the correlation between the JAK/STAT pathway in human gliomas and patients’ prognosis, which currently is unknown. Western blotting analysis and immunohistochemical staining were performed to detect JAK-1, phosphorylated JAK-1, and STAT-3 expression patterns in the biopsies from 96 patients with primary gliomas. Kaplan–Meier survival and Cox regression analyses were performed to evaluate the prognosis of patients. Western blotting analysis and immunohistochemical staining both indicated that the expression levels of JAK-1, phosphorylated JAK-1, and STAT-3 in primary glioma tissues were significantly higher than those in normal brain tissues (P < 0.001). Especially, the positive expression rates of JAK-1, phosphorylated JAK-1, and STAT-3 were significantly higher in patients with higher grade (P = 0.001, 0.001, and 0.002, respectively) and lower KPS score (P = 0.01, 0.008, and 0.01, respectively). Statistical analysis showed that patients with gliomas expressing JAK-1 and STAT-3 have lower overall survival rates relative to those not expressing these proteins. Cox multi-factor analysis showed that KPS (P = 0.03), WHO grade (P = 0.008), JAK-1 (P = 0.005), and STAT-3 (P = 0.006) were independent prognosis factors for human gliomas. These results provide convincing evidence for the first time that the JAK/STAT pathway may play a role in the progression of human gliomas. Its activated state might be a potent tool for predicting the clinical prognosis of patients with glioma.Keywords
This publication has 30 references indexed in Scilit:
- The Incidence, Correlation with Tumor-Infiltrating Inflammation, and Prognosis of Phosphorylated STAT3 Expression in Human GliomasClinical Cancer Research, 2008
- Constitutively Activated STAT3 Frequently Coexpresses with Epidermal Growth Factor Receptor in High-Grade Gliomas and Targeting STAT3 Sensitizes Them to Iressa and AlkylatorsClinical Cancer Research, 2008
- Somatically acquired JAK1 mutations in adult acute lymphoblastic leukemiaThe Journal of Experimental Medicine, 2008
- Expression levels of the JAK/STAT pathway in the transition from hormone-sensitive to hormone-refractory prostate cancerBritish Journal of Cancer, 2007
- Survivin splice variants regulate the balance between proliferation and cell deathOncogene, 2005
- Stat3 activation regulates the expression of matrix metalloproteinase-2 and tumor invasion and metastasisOncogene, 2004
- The complex identity of brain tumors: emerging concerns regarding origin, diversity and plasticityTrends in Neurosciences, 2004
- STAT proteins: From normal control of cellular events to tumorigenesisJournal of Cellular Physiology, 2003
- In vivoactivation of JAK2/STAT‐3 pathway during angiogenesis induced by GM‐CSFThe FASEB Journal, 2001
- TRANSCRIPTIONAL RESPONSES TO POLYPEPTIDE LIGANDS: The JAK-STAT PathwayAnnual Review of Biochemistry, 1995